About Index Trending news
Lists
Pricing
PharmAthene

PharmAthene

PharmAthene

The development of effective countermeasures to a range of potential biological and chemical weapons is PharmAthene’s primary objective.

Elsewhere

Alexa global traffic share

Latest funding
Secondary market
$19,300,000
Employees

Team size

50+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when PharmAthene makes some noise.